Holger Niederkrüger

Title: Holger Niederkrüger: Innovator in Glycosylated Lysosomal Proteins

Introduction

Holger Niederkrüger is a notable inventor based in Malterdingen, Germany. He has made significant contributions to the field of biochemistry, particularly in the development of glycosylated lysosomal proteins. With a total of 2 patents, his work focuses on improving therapeutic efficacy for various medical conditions.

Latest Patents

Niederkrüger's latest patents revolve around a lysosomal protein composition that includes a variety of lysosomal proteins, which are diversely glycosylated according to a specific glycosylation pattern. This pattern features at least 45% paucimannosidic N-glycans. The invention also details a method for producing this lysosomal protein composition in bryophyte plants or cells. Notably, the lysosomal proteins can include α-Galactosidase for treating Fabry Disease and β-Glucoceramidase for Gaucher's Disease. The unique glycosylation achieved through this method results in improved therapeutic efficacy, surprisingly even without the common mannose-6-phosphate found in CHO cell-produced lysosomal proteins.

Career Highlights

Throughout his career, Holger Niederkrüger has worked with several companies, including Eleva GmbH and Greenovation Biotech GmbH. His innovative approaches have positioned him as a key figure in the biotechnology sector, particularly in the development of therapeutic proteins.

Collaborations

Niederkrüger has collaborated with notable professionals in his field, including Paulina Dabrowska-Schlepp and Fode Benjamin. These collaborations have further enhanced his research and development efforts in glycosylated proteins.

Conclusion

Holger Niederkrüger's contributions to the field of glycosylated lysosomal proteins demonstrate his commitment to advancing medical therapies. His innovative patents and collaborations highlight his role as a significant inventor in biochemistry.